Skip to main content
What happens to patients with cancer engaged in biomedical research when intellectual property regimes and ethical regimes intersect? This qualitative historical study addresses this question by situating the experiences, hopes, and... more
What happens to patients with cancer engaged in biomedical research when intellectual property regimes and ethical regimes intersect? This qualitative historical study addresses this question by situating the experiences, hopes, and reasons of patients to enter clinical trials within the historical trajectory of informed consent and monoclonal antibodies, the biotechnology underpinning many targeted drugs used in oncological clinical trials and biobank research. Based on fieldwork we undertook in a German university hospital where we interviewed patients and the medical personnel, a historical review, and an ethical analysis we inquire into the effects that financial, legal, and technological changes connected to the relevant pharmaceutical research and commerce have on cancer patients engaged in clinical trials and biobank research. We find that the controversial aspects of monoclonal antibodies, especially those related to the commercial interests at stake, enter the informed consent process mainly in the form of informative gaps. We highlight how a qualitative analysis of the clinic, especially when it is situated against the backdrop of the history of related technological advancements and patent regime, it can serve the purpose of giving voice to subjects who are silenced by regimes of an ethical, epistemic, and commercial kind while pointing to informed consent as an unhelpful device for addressing risks arising from the commercial purposes of biomedical products and infrastructure.
Today, claims about the contiguity of health management and societal organization bring biopolitical concerns to the forefront. This essay offers historical-political insights on the covid-19 pandemic, which are particularly urgent, as... more
Today, claims about the contiguity of health management and societal organization bring biopolitical concerns to the forefront. This essay offers historical-political insights on the covid-19 pandemic, which are particularly urgent, as both the temporal and the cultural-political dimensions have been insufficiently considered in current debates. After introducing our specific political-epistemological approach, we delve into the entanglements of medical expertise, economic interests, surveillance politics, and diplomatic relations in the past in order to shed light on the present. Additionally, we address the limitations of Italian theory's biopolitica, namely its idle radicalization of critical views on medical politics inspired by French épistémologie historique. We conclude with a call to scientists' responsibility in consideration of the societal embedment of their activity. Yet, the task of an emancipated science is not only in their hands but depends on our collective capacity to organically connect their work to the renewal of the body politics at large.
The industrialisation of food production over the past century has triggered a series of sanitary crises related to antibiotic resistance. In this article, I contend that to understand the radical transformation of animal farming and its... more
The industrialisation of food production over the past century has triggered a series of sanitary crises related to antibiotic resistance. In this article, I contend that to understand the radical transformation of animal farming and its effects on public health, we need to inquire into the historical development of the knowledge on microbes, especially with regard to the agricultural industry’s mobilisation and repression of microbial metabolism to scale up food production. Moreover, I conceive of the so-called Great Acceleration of the Anthropocene as a postcolonial mimetic trap through which actors who didn’t play an active role in the contemporary ecological collapse are subsumed into an indistinct “we”. To disentangle this alleged collective subject created from accounts of planetary health, I focus on the scientific, social, and institutional histories of antibiotic production and antibiotic use that materialised in the epidemiological issue of antibiotic resistance. Furthermore, I highlight how the history of antibiotic use and resistance is intertwined with the ecological, social, and geopolitical dynamics created by intense industrial production and international rivalries during the Cold War. This article calls for the re-evaluation and creation of counter-narratives of the planetary impact of industry on microbes, local communities, patients, medical personnel, and the global poor.
The establishment of international sanitary institutions, which took place in the context of rivalry among the great European powers and their colonial expan-sion in Asia, allowed for the development of administrative systems of... more
The establishment of international sanitary institutions, which took place in the context of rivalry among the great European powers and their colonial expan-sion in Asia, allowed for the development of administrative systems of international epidemiological surveillance as a response to the cholera epidemics at the end of the nineteenth century. In this note, I reflect on how a historical analysis of the inception of international epidemiological surveillance and pandemic management helps us to understand what is happening in the COVID-19 pandemic today.
This article traces the historical co-evolution of microbiology, bacteriology, and virology, framed within industrial and agricultural contexts, as well as their role in colonial and national history between the end of the 19th century... more
This article traces the historical co-evolution of microbiology, bacteriology, and virology, framed within industrial and agricultural contexts, as well as their role in colonial and national history between the end of the 19th century and the first decades of the 20th century. The epistemology of germ theory, coupled with the economic interests of European colonies, has shaped the understanding of human-microbial relationships in a reductionist way. We explore a brief history of the medical and biological sciences, focusing on microbes and the difficulty of implementing germ theory outside of biology laboratories. Furthermore, we highlight the work of Lynn Margulis, who conceptualized microbes within their ecological contexts. Such research shows the active role microbes play in handling life-sustaining biological and biochemical processes. We outline how the industrial and technological advancements of the last two centuries not only impacted almost all human societies, but also changed the world on microbial, biological, and geological levels. The narration of these histories is a complex task, and depends on how national, international, and intergovernmental institutions (such as the World Health Organization) conceive of the selective environmental pressures exerted by industry and biotechnological companies.
What does it take for the life sciences to reflect on themselves and their conceptual models in the era of the technosphere? In this conversation, sociologist Hannah Landecker and historian of science Flavio D’Abramo discuss the drastic... more
What does it take for the life sciences to reflect on themselves and their conceptual models in the era of the technosphere? In this conversation, sociologist Hannah Landecker and historian of science Flavio D’Abramo discuss the drastic shifts in our understandings of body-environment dynamics made visible by recent insights within the fields of epidemiology and epigenetics. They point to the necessity of reflecting on the limits of the organism itself, given the ways in which the social, ecological, and multi-species environments are intertwined with the biological one.
Millions of people worldwide currently suffer from serious neurological diseases and injuries for which there are few, and often no, effective treatments. The paucity of effective interventions is, no doubt, due in large part to the... more
Millions of people worldwide currently suffer from serious neurological diseases and injuries for which there are few, and often no, effective treatments. The paucity of effective interventions is, no doubt, due in large part to the complexity of the disorders, as well as our currently limited understanding of their pathophysiology. The bleak picture for patients, however, is also attributable to avoidable impediments stemming from quality concerns in preclinical research that often escape detection by research regulation efforts. In our essay, we connect the dots between these concerns about the quality of preclinical research and their potential ethical impact on the patients who volunteer for early trials of interventions informed by it. We do so in hopes that a greater appreciation among preclinical researchers of these serious ethical consequences can lead to a greater commitment within the research community to adopt widely available tools and measures that can help to improve the quality of research.
Research Interests:
The field of epigenetics is leading to new conceptualizations of the role of environmental factors in health and genetic disease. Although more evidence is required, epigenetic mechanisms are being implicated in the link between low... more
The field of epigenetics is leading to new conceptualizations of the role of environmental factors in health and genetic disease. Although more evidence is required, epigenetic mechanisms are being implicated in the link between low socioeconomic status and poor health status. Epigenetic phenomena work in a number of ways: they can be established early in development, transmitted from previous generations and/or responsive to environmental factors. Knowledge about these types of epigenetic traits might therefore allow us to move away from a genetic deterministic perspective, and provide individuals with the opportunity to change their health status. Although this could be equated with patient empowerment, it could also lead to stigmatization and discrimination where individuals are deemed responsible for their health, even if they are not in social situations where they are able to enact change that would alter their health status. In this paper, we will explore the responsibilities of different actors in the healthcare sphere in relation to epigenetics across four different contexts: (1) genetic research, (2) clinical practice, (3) prenatal care and (4) the workplace. Within this exploration of role responsibilities, we will also discuss the potential constraints that might prevent the patient, mother-to-be, research participant or employee, from enacting any necessary steps in order to increase their health status in response to epigenetic information.
Personalized medicine is a new field based on molecular biology and genomics in which targeted tumor therapies are administered to patients. Psycho-oncology is a complementary approach that considers social and psychological aspects of... more
Personalized medicine is a new field based on molecular biology and genomics in which targeted tumor therapies are administered to patients. Psycho-oncology is a complementary approach that considers social and psychological aspects of patients as part of the treatments for cancer patients.

The aim of this mini-review is to weigh clinical benefits for breast cancer patients of both treatments and possibily enhance benefits by modulating the use of both interventions. We have compared and evaluated on the one hand the use of anti Vascular Endothelial Growth Factor and, on the other hand, psycho-oncological interventions in metastatic and non-metastatic breast cancer patients.

Both treatments did not increase survival of metastatic breast cancer patients, while in a selected study psycho-oncological interventions extended lifespan of non-metastatic breast cancer patients and ameliorate psychological and social factors of metastatic breast cancer patients. Because the two approaches address completely different aspects of cancer patients, if the comparison is limited to the extension of survival, the value of these two treatments cannot be assessed and compared.

It is likely that by comparing patients reported outcomes, possibly by using standardized Quality of Life questionnaires, both patients and health care providers can weigh the benefits of the two treatments. It is therefore important to evaluate the use of cancer patients’ quality of life measures as a mean to improve their experiences about life and treatment, and possibly to extend their survival.
Research Interests:
Biobanks, which contain human biological samples and/or data, provide a crucial contribution to the progress of biomedical research. However, the effective and efficient use of biobank resources depends on their accessibility. In fact,... more
Biobanks, which contain human biological samples and/or data, provide a crucial contribution to the progress of biomedical research. However, the effective and efficient use of biobank resources depends on their accessibility. In fact, making bio-resources promptly accessible to everybody may increase the benefits for society. Furthermore, optimizing their use and ensuring their quality will promote scientific creativity and, in general, contribute to the progress of bio-medical research. Although this has become a rather common belief, several laboratories are still secretive and continue to withhold samples and data. In this study, we conducted a questionnaire-
based survey in order to investigate sample and data accessibility in research biobanks operating all over the world. The survey involved a total of 46 biobanks. Most of them gave permission to access their samples (95.7%) and data (85.4%), but free and
unconditioned accessibility seemed not to be common practice. The analysis of the guidelines regarding the accessibility to resources of the biobanks that responded to the survey highlights three issues: (i) the request for applicants to explain what they would like to do with the resources requested; (ii) the role of funding, public or private, in the establishment of fruitful collaborations between biobanks and research labs; (iii)
the request of co-authorship in order to give access to their data. These results suggest that economic and academic aspects are involved in determining the extent of sample and data sharing stored in biobanks. As a second step of this study, we investigated
the reasons behind the high diversity of requirements to access biobank resources. The analysis of informative answers suggested that the different modalities of resource accessibility seem to be largely influenced by both social context and legislation of the countries where the biobanks operate.
Research Interests:
In biobank research, one of the main obstacles for full applicability of Open Access to biomedical resources is the researchers’ reluctance to make immediately and freely available these materials before having adequately exploited their... more
In biobank research, one of the main obstacles for full applicability of Open Access to biomedical resources is the researchers’ reluctance to make immediately and freely available these materials before having adequately exploited their potential. To analyse this issue from a wider perspective, we need to consider the role of research biobanks as main repositories in which human biological samples are stored, with or without accompanying them with genetic or clinical data (Haga and Beskow 2008). If withholding of biobanks’ resources drastically reduces their full value, their wide sharing is not simple to put into practice. The first and most complex barrier hindering Open Access is the lack of common standards, guidelines and legal frameworks due to socio-cultural differences of countries where biobanks operate (see Capocasa et al 2015 https://peerj.com/preprints/1212/). Developing harmonised standards is a challenge that primarily needs to foster international norms for donors’ p...
Background Appropriate information and consent has been one of the most intensely discussed topics within the context of biobank research. In parallel to the normative debate, many socio-empirical studies have been conducted to gather... more
Background
Appropriate information and consent has been one of the most intensely discussed topics within the context of biobank research. In parallel to the normative debate, many socio-empirical studies have been conducted to gather experiences, preferences and views of patients, healthy research participants and further stakeholders. However, there is scarcity of literature which connects the normative debate about justifications for different consent models with findings gained in empirical research. In this paper we discuss findings of a limited review of socio-empirical research on patients’ and healthy research participants’ experiences and views regarding consent to biobank research in light of ethical principles for appropriate information and consent.

Methods
Review question: Which empirical data are available on research participants’ perceptions and views regarding information and elicitation of consent for biobank research? Search of articles published till March 1st 2014 in Pubmed. Review of abstracts and potentially relevant full text articles by two authors independently. As categories for content analysis we defined (i) understanding or recall of information, (ii) preferences regarding information or consent, and (iii) research participants’ concerns.

Results
The search in Pubmed yielded 337 abstracts of which 10 articles were included in this study. Approaches to information and consent varied considerably across the selected studies. The majority of research participants opted for some version of limited consent when being informed about such possibility. Among the factors influencing the type of preferred consent were information about sponsoring of biobank research by pharmaceutical industry and participants’ trade-off between privacy and perceived utility. Studies investigating research participants’ understanding and recall regarding the consent procedure indicated considerable lack of both aspects. Research participants’ perceptions of benefits and harms differ across those studies.

Conclusion
The knowledge, perceptions and views of research participants who have undergone a consent procedure within the context of biobank research raise several questions on the issue of how to inform and elicit consent in an ethically acceptable way. In our empirical-ethical analysis we develop suggestions on how the practice of eliciting consent in the biobank context should be improved.
Research Interests:
1. Breve storia del consenso informato Prime spinte verso il consenso informato La dichiarazione di Helsinki La convenzione di Oviedo Il consenso informato nella regolamentazione italiana Per riassumere 2. Breve introduzione... more
1. Breve storia del consenso informato
Prime spinte verso il consenso informato
La dichiarazione di Helsinki
La convenzione di Oviedo
Il consenso informato nella regolamentazione italiana
Per riassumere

2. Breve introduzione all’evoluzione bioetica del consenso informato
La medicina paternalistica e il principio di beneficità
Il principio di autodeterminazione, lo shared decision making, e l’empowerment del paziente
La trasparenza nel rapporto medico/paziente
Per riassumere

3. Dal consenso informato alla decisione autonoma e informata
Il consenso informato tra efficacia terapeutica ed equità
Equità, giustizia sociale e medicina difensiva
Per riassumere

Conclusioni

Riferimenti Bibliografici
Research Interests:
With the rise of -omics disciplines and biobank research, personal data and biosamples crossing national borders pose new ethical questions. In this article, informed consent, as originally conceived, is shown as not being sufficient to... more
With the rise of -omics disciplines and biobank research, personal data and biosamples crossing national borders pose new ethical questions. In this article, informed consent, as originally conceived, is shown as not being sufficient to address aims of research and interests of patients any more. Therefore the author has, after having scrutinised issues in biobanking, sketched a model of dynamic consent and a manner of scrutinising ethical issues through empirical data.
The phenomenon of high cancer mortality has been the key factor in driving drug approval processes and health-care policies. In this paper, we discuss the inconsistencies of the genetic model of cancer as applied in the case of colorectal... more
The phenomenon of high cancer mortality has been the key factor in driving drug approval processes and health-care policies. In this paper, we discuss the inconsistencies of the genetic model of cancer as applied in the case of colorectal cancer (CRC). The result of relying on a genetic model of CRC is the approval of cancer drugs based on the inhibition of the epidermal growth factor receptor. The poor clinical performance of these drugs has prompted the use of a molecular biomarker to find the respondent patients. Due to the complexity of the cancer cell biological pathways, even the use of a molecular biomarker has not improved the clinical response of treated patients. Within the clinical uncertainty derived from the limited predictive value of a cancer molecular biomarker, we analyse the patient-doctor relationship. Beyond the challenge of communicating the medical uncertainty, many influences coming from the health-care system make the medical decisions biased. We analyse the ethical justification in using drugs that, at best, extend the patients’ survival for a few weeks, then we proceed to highlight the excessive cost of these drugs that create a problem for the allocation of resources for the whole society. We hold that a sensitive evaluation before the use of costly drugs for metastatic cancers must enter into the physician-patient relationship balancing the ethical concerns of the oncologist community and the need for the development of preventive policies.
The first part of the thesis is a critical analysis of the proceedings of the conferences" Towards a Theoretical Biology" founded by the Rockefeller Foundation and leaded by Conrad H. Waddington. The second part is an... more
The first part of the thesis is a critical analysis of the proceedings of the conferences" Towards a Theoretical Biology" founded by the Rockefeller Foundation and leaded by Conrad H. Waddington. The second part is an epistemological and sociological analysis ...
In the article some remarks are made on the birth and development of genetics and epigenetics, and in respect of their relationship with environmental factors. If Johannsen’s genotype concept is a reprise of Woltereck’s Norm of Reaction,... more
In the article some remarks are made on the birth and development of genetics and epigenetics, and in respect of their relationship with environmental factors. If Johannsen’s genotype concept is a reprise of Woltereck’s Norm of Reaction, is also true that the former excluded the important role of environmental factors considered by the latter. Then, I describe some operational concepts taken from Woltereck’s Norm of Reaction and that through the work of Krafka and Hersch were transferred to Conrad Waddington in the contemporary biological debate. In the light of the role that epigenetics confers to the interaction between environmental factors and organisms’ development, the importance of the genetic code is questioned.
ll volume introduce il lettore all’epigenetica, lo studio biologico della continuità tra organismi e ambienti, attraverso la sua storia e le sue attuali applicazioni nella salute pubblica e nella ricerca scientifica. Sulla scia della... more
ll volume introduce il lettore all’epigenetica, lo studio biologico della continuità tra organismi e ambienti, attraverso la sua storia e le sue attuali applicazioni nella salute pubblica e nella ricerca scientifica. Sulla scia della divisione del mondo nei blocchi delineati durante la guerra fredda, l’epigenetica venne osteggiata dalle più importanti istituzioni scientifiche occidentali di inizio Novecento e dimenticata fino alla fine degli anni sessanta. Uno dei motivi di questo ostracismo da parte degli ambienti accademici risiedeva nel carattere di forte interdisciplinarità della sua genesi – prerogativa propria della scienza sovietica – mentre nell’assetto scientifico del blocco occidentale la specializzazione disciplinare e il conseguente ruolo degli esperti nelle istituzioni democratiche iniziava a prendere piede. Dopo aver percorso le tappe storiche dello sviluppo dell’epigenetica, vengono analizzati casi di studio in cui questa disciplina interagisce con la zoologia, la botanica e la sfera della salute pubblica per le generazioni presenti e future, nonché le linee di ricerca più recenti che aprono al ripensamento dei cardini culturali e scientifici delle nostre stesse società.
Research Interests:
In this article I recognise three major historical phases of epigenetics, the first initiated by Child, Needham and Waddington during the first half of last century, focused on a dialectical analysis of biological processes between the... more
In this article I recognise three major historical phases of epigenetics, the first initiated by Child, Needham and Waddington during the first half of last century, focused on a dialectical analysis of biological processes between the organisms and their environments. The second phase started with the Bellagio conferences organised by Waddington where general principles derived from quantum physics were used to establishing a global order underpinned by scientific, objective facts beyond ethical and moral judgments. In the third phase, started with the failure of the Human Genome Project, there isn’t any consensus on the operative and philosophical notion of nature – i.e. the environmental context. Then, I highlight the necessity to reunify knowledge and moral within epigenetics.
Il volume presenta il consenso informato alla luce del dibattitto filosofico e antropologico e nel suo sviluppo storico e legale. Pensato inizialmente per proteggere i soggetti di ricerca dagli abusi dei medici, il consenso informato si è... more
Il volume presenta il consenso informato alla luce del dibattitto filosofico e antropologico e nel suo sviluppo storico e legale. Pensato inizialmente per proteggere i soggetti di ricerca dagli abusi dei medici, il consenso informato si è poi trasformato in dispositivo ideologico–liberale per contrastare il paternalismo medico e promuovere il diritto individuale all’autodeterminazione dei pazienti. L’opera mette in evidenza gli aspetti più deboli di un dispositivo etico–giuridico oramai centenario, ad esempio il suo uso in medicina difensiva, per stimolare riflessioni utili a ricontestualizzarlo con appropriatezza nell’ambito della cura dei pazienti e nello scenario più ampio dei diritti sociali.
Research Interests:
L'aperto dibattito a proposito della post-verità, l'ascesa di varie forme di populismo, il consenso che viene riconosciuto a coloro che propongono alternative facts sono alcuni dei sintomi che hanno portato ad una crisi delle figure... more
L'aperto dibattito a proposito della post-verità, l'ascesa di varie forme di populismo, il consenso che viene riconosciuto a coloro che propongono alternative facts sono alcuni dei sintomi che hanno portato ad una crisi delle figure sociali e politiche degli esperti e delle istituzioni scientifiche. Se da un lato alcuni, come S. Fuller, hanno letto l'avvento della post-verità come l'istaurarsi di una democrazia epistemologica altri, come H. Collins, hanno denunciato responsabilità politiche e intellettuali degli STS per aver minato un rapporto tra scienza e società basato su fiducia e affidabilità. Epistemologia, sociologia e storia della scienza si misurano con questo fenomeno in modo interdisciplinare tentando di comprendere la crisi dell'expertise. L'epistemologia storica fornisce un framework per analizzare concetti e controversie tecnoscientifiche nei loro contesti storicamente e socialmente determinati. La social epistemology mobilita concetti come epistemic (dis)trust, epistemic (in)justice o epistemic ignorance per capire come reputazione e consenso epistemico si formano tramite processi di attribuzione di "fiducia" o "sfiducia" che generano forme di "giustizia" o "ingiustizia" epistemica". Tali approcci possono esser sintetizzati sotto la comune etichetta di Political Epistemology nel momento in cui vengono diretti a mettere in luce gli effetti politico-ideologici del sapere tecnoscientifico. L'integrazione di questi framework con quelli forniti dagli STS può avere un effetto chiarificatore nell'analisi della crisi dell'expertise. Proponiamo dunque di aprire un'arena per discutere delle possibili intersezioni fra STS, storia e filosofia della scienza. In particolar modo è nostro interesse misurare la political epistemology con la sociologia delle controversie tecnoscientifiche e con i suoi principi metodologici di "imparzialità" e "simmetria". Fra le strategie discorsive maggiormente utilizzare vi sono quelle basate sulla costruzione di opposizioni retoriche come: 1) la tensione riduzionista a polarizzare i dibattiti in cui la scienza viene opposta all'anti-scienza, oppure 2) la falsa rappresentazione a livello pubblico di ambiti o fatti scientifici come problematici, conflittuali o controversi. Queste strategie hanno sostenuto, tramite la comunicazione scientifica, la fortuna dei populismi al fine di creare egemonia culturale e relativo consenso epistemico. Dall'altro lato, un superamento di tali strategie comunicative è stato sviluppato, ad esempio, dalle comunità locali impegnate in conflitti ambientali per il diritto alla salute attraverso alleanze con esperti e attraverso la co-produzione di pratiche scientifiche politicamente informate. In questo panel vogliamo analizzare le retoriche usate nella comunicazione scientifica per sviluppare una riflessione strategica e politica sul rapporto tra scienza, tecnologia e società. Invitiamo dunque riflessioni che analizzino: 1) Le controversie relative alla formazione e trasformazione di concetti scientifici da un punto di vista storico-ad es. tramite l'epistemologia storica; 2) il rapporto tra valori sociali e valori epistemici relativamente ai processi di costruzione della (s)fiducia e (in)giustizia epistemica-ad es. tramite political epistemology e social epistemology; 3) questioni metodologiche relative agli STS e la loro collocazione politica e sociale con un focus relativo ai conflitti sociali, relative controversie tecnoscientifiche e possibili strategie risolutive.
Research Interests:
The year 2020 has witnessed the most devastating pandemic in the past 100 years. At the time of writing more than 70 million people globally have been infected; the death toll is over one and a half million. The social, political, and... more
The year 2020 has witnessed the most devastating pandemic in the past 100 years. At the time of writing more than 70 million people globally have been infected; the death toll is over one and a half million. The social, political, and economic impact of the pandemic has been tremendous, and its longer-term consequences are yet uncertain. Local governments and health international organizations dealt with and continue to deal with this unprecedented situation in various ways. Despite national differences in responses, the pandemic exposed in critical ways the intermingling of scientific and diplomatic matters. Moreover, it resulted in widespread criticism of the World Health Organization’s (WHO) handling of the crisis.

The history of science provides a unique perspective to investigate the roots of this inseparable connection between science and diplomacy in international responses to the pandemic. In this video, produced by scholars at the Max Planck Institute for History of Science (MPIWG) and with the support of an ERC Consolidator Grant (grant agreement No770548, HRP-IAEA) at the FAU Erlangen-Nuremberg, we unfold how diplomacy has become vital for global health, and how the WHO became a key player in health diplomacy.
Questo volume si pone l’obiettivo di rimettere al centro dell’attenzione una riflessione di carattere politico sullo statuto dell’expertise nella società contemporanea. L’attuale dibattito all’interno degli studi sociali sulla scienza... more
Questo volume si pone l’obiettivo di rimettere al centro dell’attenzione una
riflessione di carattere politico sullo statuto dell’expertise nella società contemporanea. L’attuale dibattito all’interno degli studi sociali sulla scienza sembra essersi consolidato attorno a delle polarità oppositive apparentemente insormontabili: da un lato il post-modernismo relativista, risultato di un’estremizzazione del costruttivismo sociale; dall’altro il veritismo ingenuo, come adozione irriflessa delle posizioni (neo)positiviste.
In questo contesto, la figura sociale dell’esperto si trova al centro del dibattito epistemologico e politico. Cosa significa essere esperti di qualcosa? Qual è la loro funzione sociale? Come avviene il processo di attribuzione della fiducia e della sfiducia epistemologiche? Quali forme di neutralità e nonneutralità dovremmo adottare nel valutare il prodotto di una riflessione esperta? Quali metodi e prospettive abbiamo per studiare l’expertise? Per i curatori del volume è necessario aprire una tavola di discussione interdisciplinare su questi argomenti, lanciando in Italia un dibatto che all’estero è invece già largamente prolifico.
Today, claims about the contiguity of health management and societal organization bring biopolitical concerns to the forefront. This essay offers historical-political insights on the covid-19 pandemic, which are particularly urgent, as... more
Today, claims about the contiguity of health management and societal organization bring biopolitical concerns to the forefront. This essay offers historical-political insights on the covid-19 pandemic, which are particularly urgent, as both the temporal and the cultural-political dimensions have been insufficiently considered in current debates. After introducing our specific political-epistemological approach, we delve into the entanglements of medical expertise, economic interests, surveillance politics, and diplomatic relations in the past in order to shed light on the present. Additionally, we address the limitations of Italian theory's biopolitica, namely its idle radicalization of critical views on medical politics inspired by French épistémologie historique. We conclude with a call to scientists' responsibility in consideration of the societal embedment of their activity. Yet, the task of an emancipated science is not only in their hands but depends on our collective capacity to organically connect their work to the renewal of the body politics at large.